Condition: Advanced Solid Tumor · Melanoma · Head and Neck Cancer · Sponsor: Daiichi Sankyo
This is a proof-of-concept study designed to investigate HER3-DXd monotherapy in locally advanced unresectable or metastatic solid tumors. The study is enrolling cohorts of participants with melanoma \[cutaneous/acral\], squamous cell carcinomas of the head and neck (SCCHN), HER2-negative gastric cancer ovarian carcinoma, cervical cancer, endometrial cancer, bladder cancer, esophageal carcinoma, pancreatic carcinoma, prostate cancer, second-line gastric cancer, lung cancer, and breast cancer.
This description comes directly from the study's public registry record.
Daiichi Sankyo Contact for Clinical Trial Information · 9089926400 · CTRinfo@dsi.com
Always discuss trial participation with your own doctor first.
| City of Hope | Duarte, California, United States | Recruiting |
| Yale Cancer Center | New Haven, Connecticut, United States | Recruiting |
| AdventHealth Medical Group Oncology Research at Celebration | Kissimmee, Florida, United States | Recruiting |
| University of Illinois Cancer Center | Chicago, Illinois, United States | Recruiting |
| Johns Hopkins University | Baltimore, Maryland, United States | Recruiting |
| Health Partners Frauenshuh Cancer Center | Saint Louis Park, Minnesota, United States | Recruiting |
| Health Partners Cancer Center at Regions Hospital | Saint Paul, Minnesota, United States | Recruiting |
| Washington University, School of Medicine | St Louis, Missouri, United States | Recruiting |
| Roswell Park Cancer Institute IDS | Buffalo, New York, United States | Recruiting |
| Memorial Sloan Kettering Hospital | New York, New York, United States | Recruiting |
| SCRI Oncology Partners | Nashville, Tennessee, United States | Recruiting |
| The University of Texas MD Anderson Cancer Center | Houston, Texas, United States | Recruiting |
+ 73 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06172478